Aldehyde reductase (AR) activity was measured in the brain, liver and heart of 23- to 26-month-old and 3-month-old male Wistar rats, using 5 substrates (p-nitrobenzalde-hyde, D-glucuronate, D-xylose, DL-glyceraldehyde and pyridine 3-aldehyde). A significant increase of AR activity was found in whole brain of old rats with P-nitrobenzaldehyde (11 %) and D-glucuronate (24%). Results of experiments carried out with sodium valproate suggest that the AR activity increase in brain of old rats is the high-Km form. A significant increase of AR activity was found in cerebellum (26%), brainstem (19%), hypothalamus (13%), striatum (11 %) and midbrain (6%) of old rats; up to now, the determination of the enzyme activity in the different brain regions has been carried out only with P-nitrobenzaldehyde. A significant increase of AR activity of old rats was also found in liver with D-glucuronate (10%), DL-glyceraldehyde (23%) and pyridine 3-aldehyde (30%), and in heart with P-nitrobenzaldehyde (42%) and DL-glyceraldehyde (20%). A significant decrease of AR activity with D-xylose (15%) was found in heart of old rats compared to matched animals of 3 months. The present study indicates that the regulatory mechanism for AR in brain and peripheral tissues like liver and heart are different with increasing age.

Keywords:
Rat, Brain, Liver, Heart, Aldehyde reductase
This content is only available via PDF.
© 1984 S. Karger AG, Basel
1984
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.